Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
venerdì, novembre 06
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
AdaptHealth Corp
AHCO
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$7.41
-0.005
-0.07%
Ult. Agg.: Nov 6, 11:45 AM
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
Utili:
I risultati di Q3 2026 sono stati pubblicati in data mar nov 3rd, prima dell'apertura del mercato
Conference call:
La conference call più recente è iniziata alle 8:30 AM, 3 giorni fa
Clicca per vedere il webcast
AdaptHealth Financials
AdaptHealth (AHCO) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
AdaptHealth Raises FY2026 Sales Guidance from $2.850B-$2.890B to $2.880B-$2.900B vs $2.955B Est
AdaptHealth (NASDAQ:AHCO) raises FY2026 sales outlook from $2.850 billion-$2.890 billion to $2.880 billion-$2.900 billion vs $2.955 billion estimate.
Benzinga Newsdesk
PRO
AdaptHealth Q3 Sales $745.648M Miss $746.446M Estimate
AdaptHealth (NASDAQ:AHCO) reported quarterly sales of $745.648 million which missed the analyst consensus estimate of $746.446 million by 0.11 percent. This is a 9.10 percent decrease over sales of $820.314 million the
Benzinga Newsdesk
PRO
UPDATE: AdaptHealth Q2 Adj. EPS $0.08 Misses $0.17 Estimate
AdaptHealth (NASDAQ:AHCO) reported quarterly earnings of $0.08 per share which missed the analyst consensus estimate of $0.17 by 52.94 percent. This is a 20 percent decrease over earnings of $0.10 per share from the
Benzinga Newsdesk
PRO
AdaptHealth Lowers FY2026 Sales Guidance from $3.450B-$3.520B to $2.850B-$2.890B vs $3.488B Est
AdaptHealth (NASDAQ:AHCO) lowers FY2026 sales outlook from $3.450 billion-$3.520 billion to $2.850 billion-$2.890 billion vs $3.488 billion estimate.
Benzinga Newsdesk
PRO
AdaptHealth Q2 EPS $(0.99) Misses $0.18 Estimate, Sales $740.300M Miss $848.627M Estimate
AdaptHealth (NASDAQ:AHCO) reported quarterly losses of $(0.99) per share which missed the analyst consensus estimate of $0.18 by 650 percent. This is a 1090 percent decrease over earnings of $0.10 per share from the
Benzinga Newsdesk
PRO
CORRECTION: AdaptHealth Q1 Adj. EPS $(0.05) Misses $0.02 Estimate, Sales $819.799M Beat $796.621M Estimate
AdaptHealth (NASDAQ:AHCO) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $0.02 by 350 percent. This is unchanged from the same period last year. The company reported
Benzinga Newsdesk
